Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BioTime begins clinical testing of new blood plasma volume expander

April 20, 2000

FDA approves Actonel for osteoporosis prevention and treatment

April 20, 2000

Anilide MTP inhibitors presented at Pharmaceutical Society of Japan meeting

April 19, 2000

Long-term treatment with daily pegvisomant proves safe and effective as acromegaly Rx

April 19, 2000

Human chorionic gonadotropin vaccines for interrupting fertility

April 19, 2000

Yakult Honsha profiles novel ACAT inhibitor at major national industry meeting

April 18, 2000

Activella receives U.S. approval for postmenopausal osteoporosis prevention

April 18, 2000

Design and pharmacology of TSE-424, a potential osteoporosis therapy

April 14, 2000

Oral calcitonin enters phase I/II trials

April 14, 2000

WHI study continues despite early increase in cardiac events with HRT

April 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...